Scancell signs agreement with Genmab
Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer and infectious…
October 26, 2022 - 2 minutes
Genmab
Oxford BioTherapeutics enters into antibody agreement with Genmab
Oxford BioTherapeutics (OBT) says Genmab has licensed a novel antibody related to one of OBT's…
October 3, 2022 - 2 minutes
License submitted to FDA for drug to help those with large B-cell lymphoma
A biologics license application has been submitted to the US Food and Drug Administration (FDA)…
July 1, 2022 - 3 minutes
The Billion-Euro European Biotech Companies in 2022
Here’s a list of the public European biotech companies that are worth more than a…
December 20, 2021 - 12 minutes
Delayed IPOs and Market Drops Batter Biotech Stocks
Stock markets worldwide have experienced painful instability in the last few months. As a result,…
May 25, 2021 - 6 minutes
ADC Approval Buoys Spirits in Cancer Treatment Space
The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for…
May 11, 2021 - 7 minutes
EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls
While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations…
April 27, 2021 - 6 minutes
The 21 European Biotech Companies To Watch in 2021
As we enter 2021, the biotech industry is already bustling with activity. Here’s a list…
January 11, 2021 - 11 minutes
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
December 28, 2020 - 12 minutes
AbbVie and Genmab Strike €3.4B Immuno-Oncology Megadeal
AbbVie and Genmab have announced a €3.4B collaboration deal that ranks as the second biggest…
June 11, 2020 - 3 minutes
European Biotechs Showcase Multiple Sclerosis Treatments in Stockholm
Genmab, GeNeuro and other companies presented their latest data on next-generation treatments for multiple sclerosis…
September 17, 2019 - 4 minutes
Genmab’s Huge IPO Raises €450M to Develop Antibody Drugs
The Danish biotech Genmab has made a big splash on the Nasdaq, raising a €450M…
July 18, 2019 - 2 minutes
